Home » Authors » Mark McCarty

Articles by Mark McCarty

Dispute panel wants more CorCap data

Jan. 1, 2007

By Mark McCarty

No changes foreseen in FDA's regulation of DES technology

Jan. 1, 2007

By Mark McCarty

Few surprises, little new FDA action seen for addressing DES

Jan. 1, 2007

By Mark McCarty

Cost containment a central issue in state health plans

Dec. 26, 2006

By Mark McCarty

Carotid stent seen as effective with inexperienced surgeons

Dec. 22, 2006

By Mark McCarty

Drum-beat of battle continues in effort to block imaging cuts

Dec. 21, 2006

By Mark McCarty

CorCap panel outcome hints at tightening of clinical trial rules

Dec. 20, 2006

By Mark McCarty

Too little data for RESUS III as consent trial seen as onerous

Dec. 19, 2006

By Mark McCarty

Hemopure advocates say lives saved, opponents focus on SAEs

Dec. 18, 2006

By Mark McCarty

Drum-beat of battle continues in effort to block imaging cuts

Dec. 14, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...